Maureen P. Martin1, 10, Xiaojiang Gao1, 10, Jeong-Hee Lee2, 9, George W. Nelson1, Roger Detels3, James J. Goedert4, Susan Buchbinder5, Keith Hoots6, David Vlahov7, John Trowsdale8, Michael Wilson8, 9, Stephen J. O'Brien2
& Mary Carrington11
Basic Research Program, SAIC Frederick, Frederick, Maryland 21702-1201, USA.
2
Laboratory of Genomic Diversity, National Cancer Institute (NCI), Frederick, Maryland 21702-1201, USA.
3
Department of Epidemiology, School of Public Health, University of California, Los Angeles, California 90095, USA.
4
Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, Executive Plaza North, Bethesda, Maryland 20892, USA.
5
San Francisco City Clinic Cohort, San Francisco, California 94102, USA.
6
Gulf States Hemophilia Center, University of Texas Health Science Center, Houston, Texas 77030, USA.
7
The Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland 21205, USA.
8
University of Cambridge, Immunology Division, Department of Pathology, Tennis Court Road, Cambridge CB2 1QP, UK.
9
Present addresses: Department of Pathology, College of Medicine, GyeonSang National University, Chinju, South Korea (J.-H.L.); GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, UK (M.W).
10
These authors contributed equally to this work.
Correspondence should be addressed to Mary Carrington carringt@ncifcrf.gov
